Dieuwertje Kok

Dr. Dieuwertje Kok

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2015 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
DKDieuwertje Kok
Dieuwertje Kok
RDRosalie Dhonukshe-Rutten
Rosalie Dhonukshe-Rutten
CLCarolien Lute
Carolien Lute
SHSandra G. Heil
Sandra G. Heil
AUAndré G. Uitterlinden
André G. Uitterlinden
WSWilma T. Steegenga
Wilma T. Steegenga
Folate and its synthetic form folic acid function as donor of one-carbon units and have been, together with other B-vitamins, implicated in programming of epigenetic processes such as DNA methylation during early development. To what extent regulation of DNA methylation can be altered via B-vitamins later in life, and how this relates to health and disease, is not exactly known. The aim of this study was to identify effects of long-term supplementation with folic acid and vitamin B12 on genome-wide DNA methylation in elderly subjects. This project was part of a randomized, placebo-controlled trial on effects of supplemental intake of folic acid and vitamin B12 on bone fracture incidence (B-vitamins for the PRevention Of Osteoporotic Fractures (B-PROOF) study). Participants with mildly elevated homocysteine levels, aged 65–75 years, were randomly assigned to take 400 μg folic acid and 500 μg vitamin B12 per day or a placebo during an intervention period of 2 years. DNA was isolated from buffy coats, collected before and after intervention, and genome-wide DNA methylation was determined in 87 participants (n = 44 folic acid/vitamin B12, n = 43 placebo) using the Infinium HumanMethylation450 BeadChip. After intervention with folic acid and vitamin B12, 162 (versus 14 in the placebo group) of the 431,312 positions were differentially methylated as compared to baseline. Comparisons of the DNA methylation changes in the participants receiving folic acid and vitamin B12 versus placebo revealed one single differentially methylated position (cg19380919) with a borderline statistical significance. However, based on the analyses of differentially methylated regions (DMRs) consisting of multiple positions, we identified 6 regions that differed statistically significantly between the intervention and placebo group. Pronounced changes were found for regions in the DIRAS3, ARMC8, and NODAL genes, implicated in carcinogenesis and early embryonic development. Furthermore, serum levels of folate and vitamin B12 or plasma homocysteine were related to DNA methylation of 173, 425, and 11 regions, respectively. Interestingly, for several members of the developmental HOX genes, DNA methylation was related to serum levels of folate. Long-term supplementation with folic acid and vitamin B12 in elderly subjects resulted in effects on DNA methylation of several genes, among which genes implicated in developmental processes.

27 May 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Renate WinkelsRenate Winkels
Renate Winkels
RHRenate C Heine-Bröring
Renate C Heine-Bröring
MZMoniek van Zutphen
Moniek van Zutphen
SHSuzanne van Harten-Gerritsen
Suzanne van Harten-Gerritsen
DKDieuwertje Kok
Dieuwertje Kok
EKEllen Kampman
Ellen Kampman
There is clear evidence that nutrition and lifestyle can modify colorectal cancer risk. However, it is not clear if those factors can affect colorectal cancer treatment, recurrence, survival and quality of life. This paper describes the background and design of the “COlorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life” – COLON – study. The main aim of this study is to assess associations of diet and other lifestyle factors, with colorectal cancer recurrence, survival and quality of life. We extensively investigate diet and lifestyle of colorectal cancer patients at diagnosis and during the following years; this design paper focusses on the initial exposures of interest: diet and dietary supplement use, body composition, nutrient status (e.g. vitamin D), and composition of the gut microbiota.

16 May 2018 in Aging
Verified
Journal Article
Open access
BLBenthe van der Lugt
Benthe van der Lugt
FRFenni Rusli
Fenni Rusli
CLCarolien Lute
Carolien Lute
ALAndreas Lamprakis
Andreas Lamprakis
ESEthel Salazar
Ethel Salazar
WSWilma T. Steegenga
Wilma T. Steegenga
The aging process is associated with diminished colonic health. In this study, we applied an integrative approach to reveal potential interactions between determinants of colonic health in aging C57BL/6J mice. Analysis of gut microbiota composition revealed an enrichment of various potential pathobionts, including Desulfovibrio spp., and a decline of the health-promoting Akkermansia spp. and Lactobacillus spp. during aging. Intraluminal concentrations of various metabolites varied between ages and we found evidence for an increased gut permeability at higher age. Colonic gene expression analysis suggested that during the early phase of aging (between 6 and 12 months), expression of genes involved in epithelial-to-mesenchymal transition and (re)organization of the extracellular matrix were increased. Differential expression of these genes was strongly correlated with Bifidobacterium spp. During the later phase of aging (between 12 and 28 months), gene expression profiles pointed towards a diminished antimicrobial defense and were correlated with an uncultured Gastranaerophilales spp. This study demonstrates that aging is associated with pronounced changes in gut microbiota composition and colonic gene expression. Furthermore, the strong correlations between specific bacterial genera and host gene expression may imply that orchestrated interactions take place in the vicinity of the colonic wall and potentially mediate colonic health during aging.

5 July 2011 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
DKDieuwertje Kok
Dieuwertje Kok
JRJ G H van Roermund
J G H van Roermund
KAK K H Aben
K K H Aben
MHMartin Den Heijer
Martin Den Heijer
DSD W Swinkels
D W Swinkels
LKL A L M Kiemeney
L A L M Kiemeney

3 December 2018 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Open access
DKDieuwertje Kok
Dieuwertje Kok
WSWilma T. Steegenga
Wilma T. Steegenga
ESEddy J. Smid
Eddy J. Smid
EZErwin G. Zoetendal
Erwin G. Zoetendal
CUCornelia M. Ulrich
Cornelia M. Ulrich
EKEllen Kampman
Ellen Kampman
Folate is a B-vitamin with an important role in health and disease. The optimal folate status with regard to human health remains controversial. A low intake of natural folate as well as excessive intake of synthetic folic acid, were previously linked to an increased risk of colorectal cancer or with aberrant molecular pathways related to carcinogenesis in some studies. Importantly, most studies conducted so far, solely focused on dietary intake or circulating levels of folate in relation to cancer risk. Notably, diet or dietary supplements are not the only sources of folate. Several bacteria in the gastrointestinal tract can synthesize B-vitamins, including folate, in quantities that resemble dietary intake. The impact of bacterial folate biosynthesis concerning human health and disease remains unexplored. This review highlights current insights into folate biosynthesis by intestinal bacteria and its implications for processes relevant to cancer development, such as epigenetic DNA modifications and DNA synthesis. Moreover, we will reflect on the emerging question whether food-grade or intestinal bacteria can be considered a potential target to ensure sufficient levels of folate in the gastrointestinal tract and, hence the relevance of bacterial folate biosynthesis for disease prevention or treatment.

21 September 2018 in Epigenomics
Verified
Journal Article
Closed access
DKDieuwertje Kok
Dieuwertje Kok
WSWilma T Steegenga
Wilma T Steegenga
JMJill A McKay
Jill A McKay